Current trials of cytotoxic and targeted agents in breast cancer: the caveat of radiotherapy

Ann Oncol. 2011 May;22(5):1243-1244. doi: 10.1093/annonc/mdq787. Epub 2011 Feb 2.

Authors

C Chargari¹, A Levy², L Védrine³, N Magné⁴

Affiliations

¹ Department of Medical and Radiation Oncology, Val-de-Grâce Hospital, Paris. Electronic address: chargari-vdg@hotmail.fr.
² Department of Radiology, Institut Gustave Roussy, Villejuif.
³ Department of Medical and Radiation Oncology, Val-de-Grâce Hospital, Paris.
⁴ Department of Radiotherapy, Institut de Cancérologie de la Loire, Saint Priest en Jarez, France.

PMID: 21292646
DOI: 10.1093/annonc/mdq787

No abstract available

Publication types

Comment
Letter

MeSH terms

Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use*
Breast Neoplasms / drug therapy*
Breast Neoplasms / radiotherapy
Combined Modality Therapy / adverse effects
Cytotoxins / adverse effects
Cytotoxins / therapeutic use*
Female
Heart Diseases / chemically induced
Heart Diseases / etiology*
Humans
Radiation Injuries / etiology*

Substances

Antineoplastic Agents
Cytotoxins